Understanding Clinical Trial Patient Attrition

This document is a report that outlines the factors contributing to patient attrition in clinical trials and its impact on research success. It details various participant characteristics, socioeconomic and cultural factors, the informed consent process, study protocol complexity, treatment side effects, and the lack of transparent outcomes as reasons for patient dropouts. The report explains that patient attrition can significantly affect statistical power, introduce bias, and limit the generalizability of study results. Additionally, it discusses the economic implications of high attrition rates, including increased costs for drug developers. The document emphasizes the importance of understanding these factors to implement strategies that enhance patient engagement and minimize attrition. It also highlights the necessity of a people-first approach in managing patient attrition, recognizing the diverse backgrounds and needs of participants. The report concludes with the assertion that while patient attrition is a challenge, it can be managed effectively with appropriate strategies.